David Charytan, MD, MSc, of NYU Grossman School of Medicine, discusses the two most important risk factors when assessing patients with autosomal-dominant polycystic kidney disease. (0:43 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback